MAPS 2025

MAPS 2025 Decoded: The Medical Affairs Playbook for Successful Drug Launches

At the MAPS Americas 2025 conference in New Orleans, one of the pivotal discussions centered around preparing for drug launches in the current pharmaceutical landscape. While many important topics were covered, a critical element that was notably missing from the discussion was the need for a strategic north star—a guiding philosophy that ensures all tactical…...
Read More

Top Stories

DIA MASC 2025

Medical Affairs 2.0: GenAI as the Catalyst for

Digital and AI were hot topics underpinning many of the...
Biopharma 2025 Trends

Biopharma Trends 2025: 3 Things to Know Right Now

The global business climate is ever-evolving, and 2025 looks...

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Using digital enhancements to maximize engagement

Using Digital Enhancements to Maximize Engagement: How Are Pharma and Publishers Embracing Digital?

Best practices to implement digital enhancements and measure effectiveness...
Building public trust in pharma

3 Factors That Will Help Pharma Build Public Trust

Pharma must engage with patients at all levels to build public trust...
ISMPP full report image

17th Virtual Annual Meeting of ISMPP: A Summarized Report

Session summaries from the latest ISMPP conference on trust and equity in science, digital transformation...
Digital therapeutics and medical communications

Digital Therapeutics and Medical Communications: Are We Ready?

Digital Therapeutics are very new and complex, and their use will involve changing standard therapeutic...
AI in Research

Artificial Intelligence Is Democratizing Research and There’s More to Come

Today AI technologies are employed to both create and consume research. Scientists across the world...
Counting on AI: The right time for researchers and pharma

Counting on AI: The Right Time for Researchers and Pharma to Embrace Artificial Intelligence

The right AI–powered tools and techniques can make a significant difference in how research is...

Learn more ABOUT our company.